RHYTHM PHARMACEUTICALS, INC. — Form 4
Filed November 18, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
Director JEAN CHRISTOPHE (RYTM) sold 20K shares (~$1.1M) on the open market (63% of holdings). Large sale — ~63% of holdings.
Why this rating
Large sale — ~63% of holdings.
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.